Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept-Reference-Cited by-同舟云学术

Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept

Published:2006-07-25 Issue:8 Volume:26 Page:1344-1345
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Bagalas V.,Kioumis I.,Argyropoulou P.,Patakas D.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-006-0356-5.pdf

Reference10 articles.

1. YT Konttinen et al (2005) Management of rheumatic diseases in the era of biological anti-rheumatic drugs. Acta Orthop 76:614–619

2. Berman JD (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703 (Apr)

3. Ho JL et al (1994) Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapy. Biotherapy 7:223–235

4. Green SJ et al (1990) Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144:278–283 (Jan 1)

5. Tak PP et al (1996) Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077–1081 (Jul)

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Klinisch‐pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF‐α‐Inhibitoren behandelten Patienten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-05

2. Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF‐α inhibitors;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-04-12

3. Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression;PLOS Neglected Tropical Diseases;2019-08-30

4. Leishmaniasis and biologic therapies for rheumatologic diseases: a concise review;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2018-10

5. Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients;Cytokine;2016-09